Appleby advised Cartica Acquisition Corp (Cartica) on the deal. A&O Shearman represented Nidar Infrastructure. Lowenstein Sandler represented Oppenheimer & Co. Inc as lead capital markets advisor....
Cartica Acquisition Corp’s Business Combination Agreement with Nidar Infrastructure Limited
UroGen Pharma’s Follow-on Public Offering
Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
Vaxart’s $40 Million Common Stock Offering
Thompson Hine advised Vaxart, while Paul Hastings LLP advised Oppenheimer & Co. as the sole bookrunner in the offering. Vaxart, Inc. (Nasdaq: VXRT) announced an underwritten...
INOVIO Pharmaceuticals’ $36 Million Common Stock Offering
Cooley advised INOVIO Pharmaceuticals, while Paul Hastings LLP advised Oppenheimer & Co. and Citizens JMP as joint book running managers in the offering. INOVIO executed an...
Skye Bioscence’s $40 Million Private Placement Equity Financing
Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction. Skye Bioscience, Inc. (OTCQB:...
Skye Bioscience’s $50.25 Million Private Placement
Paul Hastings LLP advised the lead placement agent and the placement agent. Skye Bioscience, Inc. (OTCQB: SKYE), a clinical stage biotechnology company focused on the discovery,...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
actEvolent Health’s $402.5 Million Convertible Notes Offering
King & Spalding advised Evolent Health, Inc. on the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. Evolent Health, Inc. (NYSE:...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
Instacart’s $660 Million Initial Public Offering
Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...
Air Transport Services Group’s Convertible Senior Notes Offering
Latham & Watkins Advises on Air Transport Services Group’s Convertible Senior Notes Offering. Air Transport Services Group, Inc. (NASDAQ: ATSG) has announced the pricing of its...
Savara’s $80 Million Common Stock Offering
Holland & Knight advised Savara, and Cooley advised the underwriters. Savara announced on July 13, 2023, the pricing of an underwritten offering of 21,000,000 shares of...